US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 1.8473
  • +0.1673+9.96%
Close May 2 16:00 ET
  • 1.8300
  • -0.0173-0.94%
Post 17:18 ET
1.62MMarket Cap-54P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
-572.57%-860.78K
Net income from continuing operations
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
4.59%-469.3K
-59.70%-689.5K
Operating gains losses
69.35%-892.69K
---24.76K
---160.65K
---1.27M
--562.92K
---2.91M
----
----
----
----
Other non cash items
----
----
----
----
----
47.66%731.71K
----
----
----
----
Change In working capital
178.94%132.92K
29.15%-514.51K
-162.53%-494.89K
-773.99%-609.9K
640.60%1.75M
47.46%-168.37K
-1,023.30%-726.21K
1,749.54%791.46K
122.39%90.49K
-712.24%-324.12K
-Change in prepaid assets
125.68%245.73K
77.01%-187.44K
46.08%91.48K
-126.49%-19.8K
229.51%361.49K
---956.93K
-1,763.01%-815.19K
227.76%62.63K
--74.77K
---279.13K
-Change in payables and accrued expense
13,655.69%670.87K
165.73%456.61K
-180.45%-586.37K
-3,853.09%-590.1K
3,190.79%1.39M
101.33%4.88K
-2,444.23%-694.69K
5,320.16%728.84K
103.75%15.72K
-218.59%-45K
-Change in other working capital
-200.00%-783.68K
----
----
----
----
1,641.50%783.68K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
-572.57%-860.78K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
13.87%5.04M
-86.64%592K
0
-43.95%4.43M
-35.41%4.43M
0
Net common stock issuance
13.87%5.04M
-86.64%592K
--0
----
----
-35.41%4.43M
--4.43M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
13.87%5.04M
-86.64%592K
--0
----
----
-43.95%4.43M
-35.41%4.43M
--0
----
----
Net cash flow
Beginning cash position
12.93%7.54M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
--6.68M
149,847.93%5.06M
122,804.96%5.45M
8,070.57%5.81M
--6.68M
Current changes in cash
-622.83%-4.51M
-157.52%-1.43M
-546.44%-2.56M
327.60%819.49K
-56.83%-1.35M
-87.07%862.95K
-62.84%2.48M
-37,050.28%-395.28K
-439.61%-360.06K
-1,309.55%-860.78K
End cash Position
-59.85%3.03M
-59.85%3.03M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
12.93%7.54M
149,847.93%5.06M
122,804.96%5.45M
8,070.57%5.81M
Free cash flow
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
43.38%-360.06K
-572.57%-860.78K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K43.38%-360.06K-572.57%-860.78K
Net income from continuing operations -502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M4.59%-469.3K-59.70%-689.5K
Operating gains losses 69.35%-892.69K---24.76K---160.65K---1.27M--562.92K---2.91M----------------
Other non cash items --------------------47.66%731.71K----------------
Change In working capital 178.94%132.92K29.15%-514.51K-162.53%-494.89K-773.99%-609.9K640.60%1.75M47.46%-168.37K-1,023.30%-726.21K1,749.54%791.46K122.39%90.49K-712.24%-324.12K
-Change in prepaid assets 125.68%245.73K77.01%-187.44K46.08%91.48K-126.49%-19.8K229.51%361.49K---956.93K-1,763.01%-815.19K227.76%62.63K--74.77K---279.13K
-Change in payables and accrued expense 13,655.69%670.87K165.73%456.61K-180.45%-586.37K-3,853.09%-590.1K3,190.79%1.39M101.33%4.88K-2,444.23%-694.69K5,320.16%728.84K103.75%15.72K-218.59%-45K
-Change in other working capital -200.00%-783.68K----------------1,641.50%783.68K----------------
Cash from discontinued investing activities
Operating cash flow -167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K43.38%-360.06K-572.57%-860.78K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 13.87%5.04M-86.64%592K0-43.95%4.43M-35.41%4.43M0
Net common stock issuance 13.87%5.04M-86.64%592K--0---------35.41%4.43M--4.43M--0--------
Cash from discontinued financing activities
Financing cash flow 13.87%5.04M-86.64%592K--0---------43.95%4.43M-35.41%4.43M--0--------
Net cash flow
Beginning cash position 12.93%7.54M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M--6.68M149,847.93%5.06M122,804.96%5.45M8,070.57%5.81M--6.68M
Current changes in cash -622.83%-4.51M-157.52%-1.43M-546.44%-2.56M327.60%819.49K-56.83%-1.35M-87.07%862.95K-62.84%2.48M-37,050.28%-395.28K-439.61%-360.06K-1,309.55%-860.78K
End cash Position -59.85%3.03M-59.85%3.03M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M12.93%7.54M149,847.93%5.06M122,804.96%5.45M8,070.57%5.81M
Free cash flow -167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K43.38%-360.06K-572.57%-860.78K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg